Roka Bioscience (ROKA) Reports Narrower Q2 Loss

Roka Bioscience (NASDAQ: ROKA) reported Q2 EPS of ($11.28), versus ($15.96) reported last year. Revenue for the quarter came in at $1.4 million, versus $671 thousand reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group